Binx Health Stock / Digital HealthFounded: 2005

Binx Health is a health technology company that develops new approaches designed to diagnose and treat sexually transmitted infections (STIs). Their proprietary product is the Binx io point-of-care molecular platform, which aims to allow for rapid testing of chlamydia and gonorrhea. The platform can be used in various healthcare settings including doctor offices, urgent care facilities, and hospital emergency rooms, and strives to allow healthcare practitioners to deliver test results within 30 minutes with the goal of significantly reducing the amount of time between testing and diagnosis through traditional lab testing methods. Binx Health was founded in 2005 and is headquartered in Cambridge, MA.

Register To Buy and Sell Shares

For more details on financing and valuation for Binx Health, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Binx Health’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Binx Health.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

Binx Health investors also invested in these private companies

Wellcome Trust
EQT Life Sciences
Novartis Venture Fund
Alta Life Sciences
Hildred Capital Partners
Parian Global Management
National Institute for Health Research
Braveheart Investment Group
Technology Venture Partners UK
South West Regional Development Agency
U.K. Department of Health & Social Care


Management Team

Jeffrey Luber JD
Chief Executive Officer
Jack Crowley
Chief Financial Officer
Anna Dixon Ph.D
Chief Operating Officer & Chief Technology Officer
Michael Karsonovich
Chief Commercial Officer
Pia Olson
Senior Vice President of Human Resources
Alex Kramer
Vice President of Digital Product and Technology
Abby Wright
Vice President of Business Development and Market Access
Keith Stauffer
Vice President of Sales and Marketing, US

Board Members

Guy Nohra
Alta Life Sciences
Jean-Francois Hilaire
Joachim Rothe Ph.D
EQT Life Sciences

Frequently Asked Questions About Binx Health’s Stock

Can you buy Binx Health’s stock?
Binx Health is not publicly traded on NYSE or NASDAQ in the U.S. To buy Binx Health’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Binx Health’s stock?
Yes, you can sell stock of a private company like Binx Health. Forge can help you sell your Binx Health stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Binx Health’s stock price?
Binx Health is a privately held company and therefore does not have a public stock price. However, you may access Binx Health’s private market stock price with Forge Data.
What is Binx Health’s stock ticker symbol?
Binx Health does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Diagnostics company Binx Health banks $65M to drive growth of point-of-care testing
In a series F funding round led by Hildred Capital and EQT Life Sciences Partner, Binx Health raised $65 million.
Updated on: May 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.